Published in Br J Cancer on October 01, 1996
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey. Patient Educ Couns (2010) 1.67
Information and support for women following the primary treatment of breast cancer. Health Expect (2002) 1.58
Psychosocial interventions for patients with advanced cancer - a systematic review of the literature. Br J Cancer (2004) 1.21
How do cancer patients navigate the public information environment? Understanding patterns and motivations for movement among information sources. J Cancer Educ (2010) 1.03
Supporting hope and prognostic information: nurses' perspectives on their role when patients have life-limiting prognoses. J Pain Symptom Manage (2010) 0.98
Faith, hope, and charity: an in-depth interview study of cancer patients' information needs and information-seeking behavior West J Med (2000) 0.95
Does emotional support influence survival? Findings from a longitudinal study of patients with advanced cancer. Support Care Cancer (2004) 0.94
Predictors of patients' mental adjustment to cancer: patient characteristics and social support. Br J Cancer (1998) 0.88
Service user experiences of information delivery after a diagnosis of cancer: a qualitative study. Support Care Cancer (2007) 0.86
Giving and Receiving Emotional Support Online: Communication Competence as a Moderator of Psychosocial Benefits for Women with Breast Cancer. Comput Human Behav (2014) 0.81
Cancer support group participation in the United Kingdom: a national survey. Support Care Cancer (2010) 0.78
Management of cervical cancer: summary of SIGN guidelines. BMJ (2008) 0.78
Impact of Emotional Support on Serum Cortisol in Breast Cancer Patients. Indian J Palliat Care (2016) 0.77
A chronic care ostomy self-management program for cancer survivors. Psychooncology (2016) 0.77
The association between partner support and psychological distress among prostate cancer survivors in a nationwide study. J Cancer Surviv (2015) 0.77
A randomised controlled trial of nurse-managed trial conclusion following early phase cancer trial participation. Br J Cancer (2005) 0.77
Support group programme for relatives of terminally ill cancer patients. Support Care Cancer (2004) 0.75
Presidential Address-1976. Social support as a moderator of life stress. Psychosom Med (1976) 7.68
The health-related functions of social support. J Behav Med (1981) 2.48
Physician behaviors, patient perceptions, and patient characteristics as predictors of satisfaction of hospitalized adult cancer patients. Cancer (1990) 2.12
BACUP--the first two years: evaluation of a national cancer information service. BMJ (1988) 1.79
Victims' perceptions of social support: what is helpful from whom? J Pers Soc Psychol (1990) 1.36
Psychosocial aspects of mastectomy: I. the women's perspective. Am J Psychiatry (1978) 1.31
Cancer patients: knowledge and attitudes. Cancer (1977) 1.28
Social support, support groups, and the cancer patient. J Consult Clin Psychol (1986) 1.18
Social support and the cancer patient. Conceptual and methodologic issues. Cancer (1984) 1.17
Breast cancer: varied perceptions of social support in the illness experience. Soc Sci Med (1982) 1.09
Social support and the cancer patient. Implications for future research and clinical care. Cancer (1991) 0.92
Psychosocial adjustment to breast cancer: a review of selected literature. Int J Psychiatry Med (1979) 0.90
Emotional reactions to having cancer. Am J Roentgenol Radium Ther Nucl Med (1972) 0.90
Adaptive coping mechanisms in adult acute leukemia patients in remission. JAMA (1977) 0.84
Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA (2001) 17.91
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ (1990) 8.90
Fully informed consent can be needlessly cruel. BMJ (1993) 8.49
Left-handed DNA helices. Nature (1980) 7.26
Optimised parameters for A-DNA and B-DNA. Biochem Biophys Res Commun (1972) 7.06
Variations in breast cancer management between a teaching and a non-teaching district. Eur J Cancer (1992) 5.54
Structures for the polynucleotide complexes poly(dA) with poly (dT) and poly(dT) with poly(dA) with poly (dT). J Mol Biol (1974) 5.14
A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10
General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. BMJ (1997) 4.75
Informed consent in medical research. BMJ (1998) 4.57
Brain death in three neurosurgical units. Br Med J (Clin Res Ed) (1981) 4.34
Doctors' legal position in treating temporarily incompetent patients. BMJ (1995) 4.22
The ribosome binding sites recognized by E. coli ribosomes have regions with signal character in both the leader and protein coding segments. Nucleic Acids Res (1980) 3.74
Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ (1994) 3.52
Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet (1993) 3.36
Polymorphism of DNA double helices. J Mol Biol (1980) 3.35
Structural details of double-helix observed for DNAs containing alternating purine and pyrimidine sequences. J Mol Biol (1974) 3.33
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (2010) 3.21
Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol (1999) 3.20
Supporting problem drug users: improving methadone maintenance in general practice. Br J Gen Pract (1995) 3.15
Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12
Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain (1995) 3.09
A computer aided oligonucleotide analysis provides a model sequence for RNA polymerase-promoter recognition in E.coli. Nucleic Acids Res (1978) 3.01
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94
The agarose double helix and its function in agarose gel structure. J Mol Biol (1974) 2.94
Optimised parameters for RNA double-helices. Biochem Biophys Res Commun (1972) 2.91
Heteronomous DNA. Nucleic Acids Res (1983) 2.89
Molecular conformations and structure transitions of RNA complementary helices and their possible biological significance. Nature (1968) 2.77
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res (1985) 2.62
Refinement of the structure of B-DNA and implications for the analysis of x-ray diffraction data from fibers of biopolymers. J Mol Biol (1973) 2.61
Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care (2005) 2.61
Structures for polyinosinic acid and polyguanylic acid. Biochem J (1974) 2.58
The geometry of nucleic acids. Prog Biophys Mol Biol (1970) 2.58
Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes. Biophys J (1997) 2.56
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax (2002) 2.53
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
A point mutation G----A in exon 12 of the porphobilinogen deaminase gene results in exon skipping and is responsible for acute intermittent porphyria. Nucleic Acids Res (1989) 2.39
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36
Monitoring of large randomised clinical trials: a new approach with Bayesian methods. Lancet (2001) 2.35
The cyclotron saga continues. BMJ (1989) 2.34
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Deprivation, psychological distress, and consultation length in general practice. Br J Gen Pract (2001) 2.23
The effect of colloidal carbon on the organ distribution of sheep red cells and the immune response. Immunology (1972) 2.22
Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax (2004) 2.22
Structures for Poly(U)-poly(A)-poly(U)triple stranded polynucleotides. Nat New Biol (1973) 2.20
Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J (Clin Res Ed) (1984) 2.19
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant (2003) 2.19
Bent DNA: visualization of a base-paired and stacked A-B conformational junction. J Biol Chem (1979) 2.18
Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15
Assessment of impact of information booklets on use of healthcare services: randomised controlled trial. BMJ (2001) 2.11
Letter: The structure of polydeoxyguanylic acid with polydeoxycytidylic acid. J Mol Biol (1974) 2.09
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer (2005) 2.09
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet (1996) 2.06
Community correlates of hospital use. Health Serv Res (1984) 2.06
Models of triple-stranded polynucleotides with optimised stereochemistry. Nucleic Acids Res (1976) 2.06
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05
Trabeculectomy. Br J Ophthalmol (1972) 2.02
Hepatitis B transmission from contaminated cryopreservation tank. Lancet (1995) 1.99
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. N Engl J Med (1987) 1.98
An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health (2003) 1.96
A fellowship a year abroad: the 'pros' and 'cons'. Arch Emerg Med (1991) 1.94
Pneumocephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome. Chest (1989) 1.94
Structure of the single-stranded polyribonucleotide polycytidylic acid. J Mol Biol (1976) 1.94
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
The conformation of C-DNA. J Mol Biol (1975) 1.90
Structure of beta-poly-L-alanine: refined atomic co-ordinates for an anti-parallel beta-pleated sheet. J Mol Biol (1967) 1.87
Attitudes of patients to randomised clinical trials of cancer therapy. Eur J Cancer (1998) 1.85
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Who should treat cancer? Lancet (1981) 1.81
'Anti-bee' and 'pro-bird' changes during the evolution of hummingbird pollination in Penstemon flowers. J Evol Biol (2004) 1.81
Inhibition of growth of nonbasal planes in ice by fish antifreezes. Proc Natl Acad Sci U S A (1989) 1.80
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis. Br J Haematol (2001) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
Quality-assessed reviews of health care interventions and the database of abstracts of reviews of effectiveness (DARE). NHS CRD Review, Dissemination, and Information Teams. Int J Technol Assess Health Care (1999) 1.75
The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol (1985) 1.75
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74
The macrophage electrophoretic migration test in cancer. Clin Exp Immunol (1973) 1.71